Cargando…
Targeting of the NRL Pathway as a Therapeutic Strategy to Treat Retinitis Pigmentosa
Retinitis pigmentosa (RP) is an inherited retinal dystrophy (IRD) with a prevalence of 1:4000, characterized by initial rod photoreceptor loss and subsequent cone photoreceptor loss with accompanying nyctalopia, visual field deficits, and visual acuity loss. A diversity of causative mutations have b...
Autores principales: | Moore, Spencer M., Skowronska-Krawczyk, Dorota, Chao, Daniel L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408925/ https://www.ncbi.nlm.nih.gov/pubmed/32668775 http://dx.doi.org/10.3390/jcm9072224 |
Ejemplares similares
-
Novel homozygous mutations in the transcription factor NRL cause non-syndromic retinitis pigmentosa
por: El-Asrag, Mohammed E., et al.
Publicado: (2022) -
Whole exome sequencing identifies a novel NRL mutation in a Chinese family with autosomal dominant retinitis pigmentosa
por: Gao, Meng, et al.
Publicado: (2016) -
NRL plasma formulary
por: Book, David L
Publicado: (1983) -
Retinitis Pigmentosa: Novel Therapeutic Targets and Drug Development
por: Wu, Kevin Y., et al.
Publicado: (2023) -
Retinitis pigmentosa
por: Hamel, Christian
Publicado: (2006)